Cargando…
Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
BACKGROUND: Recruitment into randomized trials of hydroxychloroquine (HCQ) for prevention of COVID-19 has been adversely affected by a widespread conviction that HCQ is not effective for prevention. In the absence of an updated systematic review, we conducted a meta-analysis of randomized trials tha...
Autores principales: | García-Albéniz, Xabier, del Amo, Julia, Polo, Rosa, Morales-Asencio, José Miguel, Hernán, Miguel A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360718/ https://www.ncbi.nlm.nih.gov/pubmed/35943669 http://dx.doi.org/10.1007/s10654-022-00891-4 |
Ejemplares similares
-
Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers
por: Polo, Rosa, et al.
Publicado: (2023) -
Hydroxychloroquine for treatment of COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
por: de Moraes, Vinícius Ynoe, et al.
Publicado: (2022) -
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19
por: Mitjà, Oriol, et al.
Publicado: (2020) -
Hydroxychloroquine safety: A meta-analysis of randomized controlled trials
por: Eljaaly, Khalid, et al.
Publicado: (2020) -
Estimates of Overall Survival in Patients With Cancer Receiving Different Treatment Regimens: Emulating Hypothetical Target Trials in the Surveillance, Epidemiology, and End Results (SEER)–Medicare Linked Database
por: Petito, Lucia C., et al.
Publicado: (2020)